Jul 22, 2025

Entos Pharmaceuticals Secures $77.5 Million Investment for Edmonton Biomanufacturing Facility

Entos Pharmaceuticals receives $77.5 million investment to build a 103,000-square-foot biomanufacturing facility in Edmonton, enhancing Canada's genetic medicine capabilities.

Jul 22, 2025

Edmonton's Affordable Housing Initiatives Gain Momentum with New Funding

Edmonton advances affordable housing with $203M investment, aiming for 2,300+ new units, supporting rapid growth and diverse community needs.